_PRIVATE_LIMITED.webp)
Zoister Healthcare (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -52.37%
- Profit Growth -81.39%
- Ebitda 205.06%
- Net Worth -25.34%
- Total Assets -47.52%
About Zoister Healthcare (Opc)
Zoister Healthcare (Opc) Private Limited (ZHOPL) is a Company incorporated in India on 06 September 2017 (Seven years and four months 27 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mrinal Negi serves as a director at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999UR2017OPC008087
-
Company No.
008087
-
Incorporation Date
06 Sep 2017
-
Date of AGM
-
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
What products or services does Zoister Healthcare (Opc) Private Limited offer?
Zoister Healthcare (Opc) Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Health Supplement, Herbal Juice, Common Disease Medicines, Eye Drops, Respiratory System Drugs, Anti Asthma Drug, Antibacterial Drugs, Ofloxacin Tablet IP, Giloy Juice, Triphala Juice.
Who are the key members and board of directors at Zoister Healthcare (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mrinal Negi
|
Director | 06-Sep-2017 | Current |
Financial Performance of Zoister Healthcare (Opc).
Zoister Healthcare (Opc) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 52.37% decrease. The company also saw a substantial fall in profitability, with a 81.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zoister Healthcare (Opc)?
In 2020, Zoister Healthcare (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zoister Healthcare (Opc)?
Unlock and access historical data on people associated with Zoister Healthcare (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zoister Healthcare (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zoister Healthcare (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
